Constellation Pharmaceuticals
Clinical trials sponsored by Constellation Pharmaceuticals, explained in plain language.
-
New pill tested to fight aggressive prostate cancer
Disease control CompletedThis study tested a new oral drug called CPI-1205, given alongside standard prostate cancer medications (enzalutamide or abiraterone/prednisone). It aimed to find a safe and effective dose for men whose advanced prostate cancer had spread and was no longer responding to standard …
Phase: PHASE1, PHASE2 • Sponsor: Constellation Pharmaceuticals • Aim: Disease control
Last updated Apr 04, 2026 06:19 UTC
-
New pill aims to shrink spleens and ease symptoms in tough blood cancers
Disease control CompletedThis study tested an experimental pill called pelabresib, both alone and combined with an existing drug (ruxolitinib), for people with myelofibrosis and other blood cancers. The main goals were to find a safe dose and see if the treatment could reduce spleen size, ease symptoms l…
Phase: PHASE1, PHASE2 • Sponsor: Constellation Pharmaceuticals • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC